Skip to main content

Table 3 Performance metrics for all indel pathogenicity prediction tools tested

From: Evaluation of in silico pathogenicity prediction tools for the classification of small in-frame indels

Tool

TP

FP

TN

FN

Total (%)

Sens

Spec

LR+ 

LR−

PPV

NPV

AUC

MCC

All variants (1740 pathogenic; 2224 benign)

CADD

852

176

2047

886

3961 (99.9)

0.49

0.92

6.19$

0.55

0.83

0.70

0.86

0.47

CAPICE

1611

715

1500

129

3955 (99.7)

0.93

0.68

2.87+

0.11+

0.69

0.92

0.91

0.61

FATHMM-Indel

1626

572

1622

111

3931 (99.2)

0.94

0.74

3.59+

0.09+

0.74

0.94

0.91

0.68

MutPred-Indel

516

72

2116

1211

3915 (98.8)

0.30

0.97

9.08$

0.73

0.88

0.64

0.81

0.37

MutationTaster2021

1675

99

1976

36

3786 (95.5)

0.98

0.95

20.52$

0.02$

0.94

0.98

0.93

PROVEAN

1482

581

1470

82

3615 (91.2)

0.95

0.72

3.35+

0.07$

0.72

0.95

0.93

0.66

SIFT-Indel

1406

827

1287

313

3833 (96.7)

0.82

0.61

2.09

0.30+

0.63

0.80

0.43

VEST-indel

1560

385

1758

179

3882 (98.0)

0.90

0.82

4.99+

0.13+

0.80

0.91

0.93

0.71

VVP

1720

728

1481

20

3949 (99.6)

0.99

0.67

3.00+

0.02$

0.70

0.99

0.87

0.67

DDD subset (70 pathogenic; 81 benign)

CADD

45

16

65

25

151 (100)

0.64

0.80

3.25+

0.45

0.74

0.72

0.78

0.45

CAPICE

64

44

37

6

151 (100)

0.91

0.46

1.68

0.19+

0.59

0.86

0.82

0.41

FATHMM-indel

66

38

43

4

151 (100)

0.94

0.53

2.01

0.11+

0.63

0.91

0.74

0.51

MutPred-Indel

17

16

64

53

150 (99.3)

0.24

0.80

1.21

0.95

0.52

0.55

0.64

0.05

MutationTaster2021

50

19

61

19

149 (98.7)

0.72

0.76

3.05+

0.36+

0.72

0.76

0.49

PROVEAN

60

32

45

6

143 (94.7)

0.91

0.58

2.19

0.16+

0.65

0.88

0.86

0.51

SIFT-indel

60

39

41

10

150 (99.3)

0.86

0.51

1.76

0.28+

0.61

0.80

0.39

VEST-indel

62

29

51

8

150 (99.3)

0.89

0.64

2.44+

0.18+

0.68

0.86

0.87

0.53

VVP

68

70

11

2

151 (100)

0.97

0.14

1.12

0.21+

0.49

0.85

0.64

0.19

  1. Findings from the entire dataset are included in the top table, and just the novel (DDD-only) subset in the bottom table. Relative strength of likelihood ratios for application of ‘strong’ or ‘moderate’ evidence under the ACMG/ACGS variant classification criteria [33] are denoted as: $High relative strength, +Medium relative strength. Additional file 1: Fig. S1 shows ROC-AUC curves
  2. TP True positive, FP False positive, TN True negative, FN False negative, LR + positive likelihood ratio, LR− negative likelihood ratio, PPV Positive predictive value, NPV negative predictive value, AUC Area under the curve, MCC Matthews correlation coefficient